Popular topics
Health technology, digital therapeutics, biotech, and the slow remaking of medical practice through software and devices.
698 articles · Health Tech & Medtech
LSP (Life Sciences Partners), the leading life sciences investor in Europe, has recently announced that it has held its final close of LSP 6 at the $600 million (approx €530 million) hard cap.
Coronavirus has not yet been labelled a pandemic by the World Health Organisation.
Founded in 1995 in Scotland, SHE software, global health, and safety software company have announced the completion of £7 million (approx €8.2 million) Series B investment led by Frog Capital from its new growth equity fund.
Famed for shipbuilding, Belfast in Northern Ireland has witnessed a significant growth in terms of tech startups.
Clear, the Dutch tech startup that measures blood glucose levels in real-time using a chip-implanted arm patch and an app has secured €780K in the seed round led by Healthy.Capital and early-stage VC and startup generator, Antler.
Neuroplast is a company based in Maastricht (the Netherlands) developing autologous stem cell therapies for patients suffering from neurodegenerative diseases such as spinal cord injury (SCI), amyotrophic lateral sclerosis (ALS) and traumatic brain injury.
Headquartered in Paris, Inato helps biopharmaceutical companies increase the pool of available patients engaged in clinical trials by discovering untapped research site potential.
Founded by Barnaby Perks and Daniel Freeman in 2016, Oxford VR is a spin-out from Oxford University built on the work of Professor Daniel Freeman, who has been developing effective VR-based mental health treatments for 15 years.
Oxford is home to the oldest university in the United Kingdom, the University of Oxford.
Concerns regarding mental health are on the rise these days and it is of increasing priority in the workplace.
Lunaphore Technologies SA, a Swiss life-sciences company, developing innovative next-generation equipment for cancer research and tissue diagnostics, announces the first closing of its Series C funding, amounting to CHF 23 million (approx €21 million).
Medicus AI, the Vienna-based health tech company, today announced that it had received a Class I Medical Device CE Mark for its mobile application.
